Heron Therapeutics Inc vs Xcel Energy Inc — how do they compare? Heron Therapeutics Inc trades at $0.35 (market cap $61.47M), while Xcel Energy Inc trades at $78.31 (market cap $48.51B). The key difference: Xcel Energy Inc is far larger — about 789.2× Heron Therapeutics Inc's market cap, and Xcel Energy Inc pays a 3.05% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | XEL | |
|---|---|---|
Market Cap | $61.47M | $48.51B |
Sector | Health | Utilities |
52-Week High | $1.49 | $83.91 |
52-Week Low | $0.32 | $71.75 |
Enterprise Value | $168.21M | $86.82B |
Dividend Yield | — | 3.05% |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
XEL trades at $78.09, up 1.59% today, with a bearish technical signal from moving averages but neutral oscillators. Recent earnings beat expectations in Q2 2026 with EPS of $0.93, driven by infrastructure investments. The company maintains solid fundamentals, including a 15.28% net income margin and a $0.59 quarterly dividend, while analyst consensus is bullish with a $93.80 price target.
Outlook is positive due to strong earnings growth and a $60 billion capital plan supporting future expansion, but risks include regulatory pushback and high debt levels. The stock offers stability with a 2.87% dividend yield, though technical resistance near $79 may limit near-term gains.
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →